quality in investigational drugs presented by: larry parker, bsmt (ascp), mhsa, asq cqa american...

52
Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

Upload: lee-phelps

Post on 26-Dec-2015

217 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

Quality In Investigational Drugs

Presented by: Larry Parker, BSMT (ASCP), MHSA,

ASQ CQA

American Society for Quality Central Arkansas Section 1407

Page 2: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

What do you expect from the medicines that you take?

Page 3: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

What do you expect from the medicines that you take?• Expect them to work.

Page 4: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

What do you expect from the medicines that you take?• Expect them to work.• Expect them to be safe.

Page 5: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

How does FDA make sure that medicines used in the United States are safe and effective?

Page 6: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

How does FDA make sure that medicines used in the United States are safe and effective?• Regulations based on scientific quality.

Page 7: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

How does FDA make sure that medicines used in the United States are safe and effective?• Regulations based on scientific quality.• Inspections based on the regulations.

Page 8: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

How does FDA make sure that medicines used in the United States are safe and effective?• Regulations based on scientific quality.• Inspections based on the regulations.• Enforcement actions for companies and

individuals based on public health law.

Page 9: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

Safety First

The first thing FDA requires is that you show a drug product is safe.

Page 10: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

Safety First

The first thing FDA requires is that you show a drug product is safe.• FDA will almost always require that there are

animal safety studies done before a new drug can be given to a human.

Page 11: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

Safety First

The first thing FDA requires is that you show a drug product is safe.• FDA will almost always require that there are

animal safety studies done before a new drug can be given to a human.

• Animal studies are regulated under the Good Laboratory Practices (GLPs) found in 21 CFR 58

Page 12: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

Safety First

Quality in the GLPs is insured in the following ways:

Page 13: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

Safety First

Quality in the GLPs is insured in the following ways:1. Facilities that conduct GLP studies must allow

FDA to inspect them.

Page 14: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

Safety First

Quality in the GLPs is insured in the following ways:1. Facilities that conduct GLP studies must allow

FDA to inspect them.2. Each animal facility must have a quality

assurance unit that inspects all it studies

Page 15: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

Safety First

Quality in the GLPs is insured in the following ways:1. Facilities that conduct GLP studies must allow

FDA to inspect them.2. Each animal facility must have a quality

assurance unit that inspects all it studies3. Written protocols are followed by the facility

for the conduct of each study

Page 16: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

Safety First

Quality in the GLPs is insured in the following ways:1. Facilities that conduct GLP studies must allow

FDA to inspect them.2. Each animal facility must have a quality

assurance unit that inspects all it studies3. Written protocols are followed by the facility for

the conduct of each study4. Equipment used in each study is validated for

use in the study prior to the start of the study

Page 17: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

Safety First: On to humans

Before FDA will allow use of a new drug in human studies you must file an Investigational New Drug (IND) application for their review.

Page 18: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

Safety First: On to humans

Before FDA will allow use of a new drug in human studies you must file an Investigational New Drug (IND) application for their review.INDs contain:• The clinical protocol that is intend for use in

humans

Page 19: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

Safety First: On to humans

Before FDA will allow use of a new drug in human studies you must file an Investigational New Drug (IND) application for their review.INDs contain:• The clinical protocol that is intend for use in

humans• Animal Safety Data

Page 20: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

Safety First: On to humans

Before FDA will allow use of a new drug in human studies you must file an Investigational New Drug (IND) application for their review.INDs contain:• The clinical protocol that is intend for use in

humans• Animal Safety Data• Drug product manufacturing information

Page 21: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

Safety First: On to humans

Before FDA will allow use of a new drug in human studies you must file an Investigational New Drug (IND) application for their review.INDs contain:• The clinical protocol that is intend for use in

humans• Animal Safety Data• Drug product manufacturing information• All references intended to support the application

Page 22: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

INDs

What does FDA expect you to know about a new drug that is going to be used in Humans?

Page 23: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

INDs

What does FDA expect you to know about a new drug that is going to be used in Humans?• Identity

Page 24: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

INDs

What does FDA expect you to know about a new drug that is going to be used in Humans?• Identity• Strength

Page 25: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

INDs

What does FDA expect you to know about a new drug that is going to be used in Humans?• Identity• Strength• Potency

Page 26: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

INDs

What does FDA expect you to know about a new drug that is going to be used in Humans?• Identity• Strength• Potency• Purity

Page 27: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

INDs

What does FDA expect you to know about a new drug that is going to be used in Humans?• Identity• Strength• Potency• Purity• Quality

Page 28: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

INDs

What does FDA expect you to know about a new drug that is going to be used in Humans?• Identity• Strength• Potency• Purity• Quality

Everything!

Page 29: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

GMPs

You know everything about a investigational drug product based on the Good Manufacturing Practice Regulations (cGMPs) found in 21 CFR 210 & 211

Page 30: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

GMPs

The GMPs:• Define the responsibilities of a companies

Quality Control Unit

Page 31: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

GMPs

The GMPs:• Define the responsibilities of a companies

Quality Control Unit• Define the minimum qualifications for QA

personnel

Page 32: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

GMPs

The GMPs:• Define the responsibilities of a companies

Quality Control Unit• Define the minimum qualifications for QA

personnel• Define the minimum specifications for

facilities and equipment

Page 33: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

GMPs

The GMPs:• Define the responsibilities of a companies

Quality Control Unit• Define the minimum qualifications for QA

personnel• Define the minimum specifications for facilities

and equipment• Provide requirements for control of

components and products

Page 34: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

GMPs

The GMPs:• Define the responsibilities of a companies Quality Control

Unit• Define the minimum qualifications for QA personnel• Define the minimum specifications for facilities and

equipment• Provide requirements for control of components and

products• Provide for controls on processing, production, packaging,

labeling, holding, and distribution of drug product

Page 35: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

GMPsThe GMPs:• Define the responsibilities of a companies Quality Control

Unit• Define the minimum qualifications for QA personnel• Define the minimum specifications for facilities and

equipment• Provide requirements for control of components and

products• Provide for controls on processing, production, packaging,

labeling, holding, and distribution of drug product• Also provides minimum requirements for laboratory

controls, records and reports

Page 36: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

But does it work?

Page 37: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

But does it work?

• Phase II clinical trials involve drugs that have successfully completed safety testing and start to look and see if a drug is effective and why it is effective.

Page 38: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

But does it work?

• Phase II clinical trials involve drugs that have successfully completed safety testing and start to look and see if a drug is effective and why it is effective.

• Phase III clinical trials use all the information found in the earlier phases and expand it to large numbers of subjects in different locations to verify that the data is still the same.

Page 39: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

Marketing a drug

• After you have completed the Phase III trials you can file for marketing clearance with FDA in order to be able to sell the drug.

Page 40: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

Marketing a drug

• After you have completed the Phase III trials you can file for marketing clearance with FDA in order to be able to sell the drug.

• Quality doesn’t stop there! FDA requires “post-marketing” studies usually called Phase IV studies that are on going as long as the drug is on the market.

Page 41: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

Questions:

Page 42: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

Quality Workshop

Quality By Design:

Page 43: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

What is QbD?

Page 44: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

What is QbD?

• FDA push to improve the drug development process

Page 45: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

What is QbD?

• FDA push to improve the drug development process

• Seeks to reduce the cost of product development due to low efficiencies, waste, and manufacturing time requirements due to testing

Page 46: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

What is QbD?

• FDA push to improve the drug development process

• Seeks to reduce the cost of product development due to low efficiencies, waste, and manufacturing time requirements due to testing

• FDA states that you can’t test quality into a product, it must be designed there

Page 47: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

What is QbD?

• A scientific, risk-based, holistic and proactive approach to pharmaceutical development.

Page 48: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

What is QbD?

• A scientific, risk-based, holistic and proactive approach to pharmaceutical development.

• A deliberate design effort from product conception through commercialization.

Page 49: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

What is QbD?

• A scientific, risk-based, holistic and proactive approach to pharmaceutical development.

• A deliberate design effort from product conception through commercialization.

• Manufacturer’s should have a full understanding of how product attributes and process relate to product performance

Page 50: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

QbD System

Page 51: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

Better View

Page 52: Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407

Another Flow Chart